DocGo (DCGO) Stock Price
DocGo Price
DocGo (DCGO) Stock | ISIN US2560861096. The current DocGo stock price is 0.53 USD (2026). Revenue is 297.18 M USD. Net income is -34.32 M USD. The P/E ratio is -1.69. Market capitalization is 51.84 M USD. DocGo operates in the Health sector.
Over the last 4 years DocGo grew revenue by 60% annually, reaching 616.56 M USD. Earnings per share have declined at 9.9% per year over the last 3 years. For DocGo, the net margin of 3.2% is up versus -15.3% a few years ago.
DocGo stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of DocGo over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how DocGo stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing DocGo's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | DocGo Price |
|---|
DocGo Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
DocGo Income Statement, Balance Sheet, Cash Flow Statement
| REVENUE (M USD) |
|---|
| REVENUE GROWTH (%) |
| GROSS MARGIN (%) |
| GROSS INCOME (M USD) |
| NET INCOME (M USD) |
| NET INCOME GROWTH (%) |
| SHARES (M) |
| DOCUMENTS |
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | 2026e | 2027e |
|---|---|---|---|---|---|---|---|
| 94 | 318 | 440 | 624 | 616 | 323 | 297 | 324 |
| – | 238.3 | 38.36 | 41.82 | -1.28 | -47.56 | -8.05 | 9.09 |
| 32.98 | 34.28 | 35 | 31.25 | 34.58 | 65.94 | 71.72 | 65.74 |
| 31 | 109 | 154 | 195 | 213 | 213 | 213 | 213 |
| -14 | 23 | 34 | 6 | 19 | -53 | -34 | -22 |
| – | -264.29 | 47.83 | -82.35 | 216.67 | -378.95 | -35.85 | -35.29 |
| 58.4 | 94.9 | 103 | 105.62 | 109.42 | 109.42 | 109.42 | 109.42 |
| – | – | – | – | – | – | – | – |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales DocGo generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue DocGo retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare DocGo's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares DocGo has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against DocGo's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
DocGo stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
DocGo Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
DocGo business model & stock analysis
DocGo SWOT Analysis
Strengths
DocGo Inc is backed by a highly experienced and competent team of medical professionals, software engineers, and business experts. This diverse expertise enables the company to develop innovative and effective solutions for the healthcare industry.
The company's flagship product, DocGo App, provides a user-friendly interface that allows patients to easily manage their medical records, schedule appointments, and communicate with healthcare providers. This convenience enhances patient satisfaction and engagement.
DocGo Inc has established strong partnerships with leading healthcare institutions and medical professionals. These partnerships help the company to expand its reach, improve product quality, and gain a competitive edge in the market.
Weaknesses
Being a relatively new entrant in the market, DocGo Inc faces challenges in terms of brand recognition and establishing trust among potential users. This could lead to slower adoption rates and difficulty in attracting a large user base initially.
The company's reliance on technology and digital platforms for its services may pose a barrier to adoption for individuals who are less tech-savvy or have limited access to digital devices and internet connectivity.
Opportunities
The increasing adoption of telemedicine and remote healthcare services presents a significant opportunity for DocGo Inc. The company's platform can facilitate virtual consultations, remote monitoring, and electronic prescriptions, addressing the growing demand for convenient and efficient healthcare solutions.
DocGo Inc can explore collaborations with insurance providers to integrate their platform with insurance networks. This would enable seamless claims processing, streamlined healthcare management, and improved cost efficiency for patients and healthcare facilities alike.
Expansion into international markets, where telemedicine and digital health solutions are gaining traction, can provide DocGo Inc with access to a larger customer base and increased revenue streams. Localizing the platform to cater to specific languages and healthcare systems would be necessary for success in these markets.
Threats
The competitive landscape in the digital healthcare industry is intensifying, with both established players and new startups entering the market. DocGo Inc needs to differentiate its offerings and continuously innovate to stay ahead and maintain market share.
Data security and privacy concerns are critical in the healthcare sector. Any breach or unauthorized access to patient data could lead to severe reputational damage and legal consequences. DocGo Inc must invest in robust security measures to protect users' sensitive information.
Regulatory compliance is another potential threat for DocGo Inc. The company must stay updated with evolving healthcare regulations and ensure its platform adheres to data protection, user privacy, and medical compliance standards in all jurisdictions where it operates.
DocGo Segments
DocGo Revenue by Segment (1/2)
Max
Details
DocGo Revenue by Segment (2/2)
Max
Details
DocGo Revenue by Region
Max
Details
DocGo Eulerpool Fair Value
DocGo historical P/E ratio, EBIT multiple, and P/S ratio
DocGo annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
DocGo shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
DocGo Earnings Estimates
DocGo Earnings Estimates
| Date | EPS estimate | Revenue Estimate | Quarterly report |
|---|---|---|---|
| 5/11/2026 | -0.1USD | 73.87 MUSD | 2026 Q1 |
| 5/6/2026 | -0.11USD | 73.87 MUSD | 2026 Q1 |
| 3/16/2026 | -0.13USD | 71.76 MUSD | 2025 Q4 |
| 2/25/2026 | -0.13USD | 71.76 MUSD | 2025 Q4 |
| 8/7/2025 | -0.1USD | 79.12 MUSD | 2025 Q2 |
| 5/6/2024 | 0.09USD | 200.76 MUSD | 2024 Q1 |
| 3/11/2024 | 0.11USD | 198.1 MUSD | 2023 Q4 |
| 11/6/2023 | 0.09USD | 130.13 MUSD | 2023 Q3 |
| 8/7/2023 | 0.08USD | 123.9 MUSD | 2023 Q2 |
EESG©
Eulerpool ESG Scorecard© for the DocGo stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
DocGo shareholder structure
| % | Name |
|---|---|
5.99248% | |
5.43514% | |
5.27124% | |
5.05221% | |
3.27165% | |
3.13961% | |
2.94273% | |
2.20427% | |
2.19247% | |
1.96065% |
DocGo Executives and Management Board
Mr. Lee Bienstock
(41)Chief Executive Officer, Director · since 2022
Mr. Norman Rosenberg
(55)Chief Financial Officer, Treasurer
Mr. Stephen Sugrue
(53)Chief Compliance Officer
Mr. Ely Tendler
(57)General Counsel, Company Secretary, Director · since 2021
Dr. Stephen Klasko
(71)Independent Chairman of the Board
Frequently asked questions about DocGo
The business model of DocGo Inc revolves around providing on-demand medical transportation services. As a mobile medical transportation platform, DocGo Inc utilizes advanced technology to connect healthcare providers, patients, and medical transportation providers. Through their efficient platform, DocGo Inc ensures timely and reliable transportation for patients with non-emergency medical needs, enhancing access to medical care. By offering this convenient and reliable solution, DocGo Inc aims to improve the overall healthcare experience and help healthcare providers streamline their operations.
DocGo stock
DocGo Peer Group
DocGo Ticker
DocGo FIGI
All fundamentals and in-depth analysis of DocGo
Our stock analysis for DocGo Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of DocGo Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.